1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Kontour (Xi'an) Medical Technology Co., Ltd. Class A

Kontour (Xi'an) Medical Technology Co., Ltd. Class A

688314.SS
Kontour (Xi'an) Medical Technology Co., Ltd. Class ACN flagShanghai Stock Exchange
32.91
CNY
+0.04
- -
2.67BMarket Cap
Kontour (Xi'an) Medical Technology Co., Ltd. Class A
688314.SS
(Shanghai Stock Exchange)

Recent

price

32.91

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1.24
1.84
2.48
2.68
2.92
2.95
3.39
3.97
4.3
4.23
Revenue per Share
0.17
0.37
0.87
0.86
1.12
0.93
0.93
1.09
1.21
1.18
Basic EPS, GAAP
0.18
0.31
0.81
-0.25
0.66
0.91
0.87
1.14
0.82
-0.53
Free Cash Flow per Basic Share
- -
- -
0.01
0.01
0.42
0.45
0.39
0.53
0.4
0.39
Dividend per Share
0.62
0.93
0.95
1.68
2.2
2.33
3.03
3.48
4.34
4.02
Book Value per Share
1.26
1.69
2.84
3.48
6.53
6.36
6.95
7.45
7.3
8.09
Tangible Book Value per Share
59
60
60
61
73
81
81
81
82
80
Basic Weighted Avg Shares
72
110
148
164
213
240
275
322
351
339
Sales/Revenue/Turnover
17.58
22.72
41.26
32.83
41.09
35.45
35.89
37.87
35.77
36.92
Operating Margin (%)
3
6
6
6
11
12
12
14
16
- -
Depreciation Expense
10
22
52
52
82
76
76
88
99
95
Net Income, GAAP
17.79
12.12
15.87
12.19
14.9
16.17
18.83
17.33
15.38
16.25
Effective Tax Rate (%)
13.88
20.23
35.14
31.93
38.4
31.54
27.46
27.46
28.11
27.91
Profit Margin (%)
51
64
139
102
314
317
347
324
338
352
Working Capital
- -
4
- -
4
3
2
1
7
41
7
LT Debt
102
127
192
243
501
542
586
638
724
683
Total Equity
- -
18.5
30.49
20.02
18.54
12.62
13.05
15.24
14.07
15.01
Return on Invested Capital (%)
- -
46.39
85.41
57.63
54.43
38.36
30.6
29.68
26.15
28.62
Return on Capital (%)
- -
48.07
92.56
65.71
62.11
43.31
34.66
33.47
31.04
31.99
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
38
38
38
LT Borrowings
- -
- -
- -
LT Finance Leases
7
7
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
81
81
81
Market Capitalization
2,297
2,123
2,475

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
418
420
433
Cash, Cash Equivalents & STI
379
375
389
Accounts Receivable, Net
6
7
9
Inventories
25
28
25
Total Current Liabilities
94
84
81
Payables & Accruals
- -
- -
- -
ST Debt
38
38
38
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
28.97%
13.51%
Free Cash Flow
- -
-72.97%
-28.22%
Net Income, GAAP
- -
15.41%
11.66%
Sales/Revenue/Turnover
- -
16.63%
9.05%
Total Cash Common Dividend
- -
1,837.61%
-23.23%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
70
83
87
82
322
2025
82
88
100
- -
351
2026
74
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.25
- -
- -
- -
1.09
2025
0.3
- -
- -
- -
1.21
2026
0.16
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.53
2025
0.01
- -
- -
- -
0.4
2026
0.01
- -
- -
- -
- -
Similar Companies
Basma Adeem Medical Co. (9626.SR)
Cofoe Medical Technology Co.,Ltd. (1187.HK)
Subgen AI AB (SUBGEN.ST)
Aidite Qinhuangdao Technology Co Ltd (301580.SZ)
Jenscare Scientific Co., Ltd. (9877.HK)
i-SENS, Inc. (099190.KQ)
Business
Kontour (Xi'an) Medical Technology Co., Ltd. Kontour (Xi'an) Medical Technology Co., Ltd. (688314.SS) is a China-based high-tech enterprise engaged in the research, development, production, and sales of Class III implantable medical devices. The company offers a comprehensive portfolio of products including titanium and poly-ether-ether-ketone (PEEK) skull repair and fixation systems such as PEEK bone plates, titanium mesh plates, PEEK link plates, titanium link plates, screws, trial molds, bone plugs, bone mesh, and bone plug strips; sternum fixation products for cardiothoracic surgery; maxillofacial repair solutions; neurospine products; disposable brain drainage devices; dental implants, implant guides, titanium mesh, GBR series nails, dental tool boxes, and related surgical auxiliary instruments; as well as supporting surgical tools. These products serve neurosurgery cranial repair and fixation, cardiothoracic surgery sternal fixation, maxillofacial repair, stomatology, and related fields, with distribution in domestic Chinese markets and overseas. Founded in 2005 and headquartered in Xi'an, Shaanxi Province, China, the company operates primarily in the medical devices sector, targeting hospitals, surgeons, and healthcare providers with advanced CAD/CAM and 3D printing technologies for precision-engineered implants. It holds over 30 international patents across three continents and maintains ISO certification, emphasizing patient-specific solutions, bioadaptive materials, and AI-enhanced surgical planning. In recent developments, Kontour (Xi'an) Medical Technology released its fiscal 2025 third quarter earnings on October 27, 2025, reporting revenue of CNY 80.77 million and earnings per share of CNY 0.2614, reflecting ongoing operational performance amid a net profit attributable to the parent of CNY 76.72 million for the first three quarters. The company continues to pursue strategic partnerships with leading medical institutions to advance next-generation implant technologies and clinician training programs, while participating in global events such as WHX Miami 2025 to expand its network. No major acquisitions, funding rounds, or name changes have been reported in the last 1-2 years, with focus remaining on R&D innovation and domestic market strengthening.